Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache

Am J Emerg Med. 2016 Sep;34(9):1916.e1-2. doi: 10.1016/j.ajem.2016.02.033. Epub 2016 Feb 12.

Authors

A H Miller¹, J A Monteiro de Oliveira Novaes², P A Brock², M Sandoval²

Affiliations

¹ University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030. Electronic address: [email protected].
² University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.

PMID: 26947375
DOI: 10.1016/j.ajem.2016.02.033

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / adverse effects*
Bevacizumab / adverse effects*
Brain / diagnostic imaging
Carcinoma / drug therapy
Carcinoma / secondary
Chest Pain / etiology
Female
Headache / etiology
Humans
Magnetic Resonance Imaging
Middle Aged
Ovarian Neoplasms / drug therapy
Ovarian Neoplasms / pathology
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / complications
Posterior Leukoencephalopathy Syndrome / diagnostic imaging

Substances

Antineoplastic Agents
Bevacizumab